DEFA14A ·Filed Apr 22, 2026
Proxy solicitation materials
Actionable Insight • Neutral
Monitor for the post-meeting 8-K filing which will report the voting results.
TSHA drugs
TSHA drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60Entry
$6.72
T+0 close · Apr 22, 2026 · via day close
Latest settled
−11.31%
T+60 · $5.96
Vs SPY
−16.09%
α at T+60
Horizons
All settled
through T+60
- T+0 · Apr 22 $6.72entry
- T+1 · 7mo ago −4.76%α −4.37% · $6.40
- T+5 · 7mo ago −3.42%α −3.48% · $6.49
- T+20 · 6mo ago −22.84%α −26.01% · $5.19
- T+60 · 4mo ago −11.31%α −16.09% · $5.96
Price Chart
REPLAYWatch the reaction play outLoading chart...
How similar events traded
Executive Summary
Taysha Gene Therapies, Inc. is holding its 2026 Annual Meeting to vote on director elections, auditor ratification, executive compensation, and vote frequency. This is a routine shareholder meeting announcement.
Key Financial Metrics
Vote
director election
Meeting
2026-06-01
Key Facts
- TSHA is holding its 2026 Annual Meeting to vote on director elections, auditor ratification, executive compensation, and vote frequency.
- The meeting is virtual and scheduled for June 1, 2026.
- This is a standard proxy statement filing for a routine annual shareholder meeting.
Financial Impact
Routine annual meeting with no immediate financial impact.
director_electionauditor_ratificationexecutive_compensation
Risk Factors
- None identified for this routine filing.
Market Snapshot
Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001193125-26-168533 |
| Document: 0001193125-26-168533-index-headers.html | 0001193125-26-168533 |
| Document: 0001193125-26-168533-index.html | 0001193125-26-168533 |
| Document: 0001193125-26-168533.txt | 0001193125-26-168533 |
Track record
14 reports on TSHA
2 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +20.50% at T+60 after the Jun 25, 2026 report. 3 of 3 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $4.06 Now $4.06 −0.00% settles Feb 16
- Nov 12, 20264d ago Press Release Neutral 5/10 Entry $4.21 Now $4.06 −3.56% settles Feb 10
- Aug 11, 202613w ago Press Release Neutral 5/10 Entry $6.41 to $4.09 Now $4.06 −36.61% ▼ −36.14% −31.03% vs SPY
- Jun 25, 202620w ago 8-K Mixed 5/10 Entry $6.34 to $5.04 Now $4.06 −35.96% ▼ −20.50% −26.61% vs SPY
- Jun 25, 202620w ago 424B5 Bearish 6/10 Entry $6.34 to $5.04 Now $4.06 +35.96% ▲ +20.50% +26.61% vs SPY
- Jun 24, 202620w ago Press Release Bearish 7/10 Entry $6.21 to $5.02 Now $4.06 +34.62% ▲ +19.16% +22.89% vs SPY
- Jun 5, 202623w ago Press Release Neutral 2/10 Entry $5.50 to $5.69 Now $4.06 −26.18% ▲ +3.45% −0.55% vs SPY
- May 6, 202627w ago 8-K Neutral 5/10 No price data
- May 6, 202627w ago Press Release Mixed 7/10 Entry $6.98 to $5.86 Now $4.06 −41.83% ▼ −16.05% −18.11% vs SPY
- Apr 29, 202628w ago Press Release Neutral 1/10 Entry $6.27 to $5.52 Now $4.06 −35.25% ▼ −11.96% −16.07% vs SPY
Showing 10 of 14
US Market Status
Market Closed · Opens in 5h 43m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers